HEADER APOPTOSIS 13-MAY-11 2LD4 TITLE SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN ANAMORSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANAMORSIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN RESIDUES 1-172; COMPND 5 SYNONYM: CYTOKINE-INDUCED APOPTOSIS INHIBITOR 1, FE-S CLUSTER COMPND 6 ASSEMBLY PROTEIN DRE2 HOMOLOG; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CIAPIN1, CUA001, PRO0915; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21-CODONPLUS (DE3)-RIPL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCOLD-DEST KEYWDS METHYLTRANSFERASE-LIKE FOLD, ALPHA/BETA FOLD, IRON-SULFUR PROTEIN KEYWDS 2 BIOGENESIS, APOPTOSIS EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR L.BANCI,I.BERTINI,S.CIOFI-BAFFONI,F.BOSCARO,A.CHATZI,M.MIKOLAJCZYK, AUTHOR 2 K.TOKATLIDIS,J.WINKELMANN REVDAT 2 01-MAY-24 2LD4 1 REMARK SEQADV REVDAT 1 13-JUL-11 2LD4 0 JRNL AUTH L.BANCI,I.BERTINI,S.CIOFI-BAFFONI,F.BOSCARO,A.CHATZI, JRNL AUTH 2 M.MIKOLAJCZYK,K.TOKATLIDIS,J.WINKELMANN JRNL TITL ANAMORSIN IS A [2FE-2S] CLUSTER-CONTAINING SUBSTRATE OF THE JRNL TITL 2 MIA40-DEPENDENT MITOCHONDRIAL PROTEIN TRAPPING MACHINERY. JRNL REF CHEM.BIOL. V. 18 794 2011 JRNL REFN ISSN 1074-5521 JRNL PMID 21700214 JRNL DOI 10.1016/J.CHEMBIOL.2011.03.015 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TOPSPIN, AMBER 10.0 REMARK 3 AUTHORS : BRUKER BIOSPIN (TOPSPIN), CASE, DARDEN, CHEATHAM, REMARK 3 III, SIMMERLING, WANG, DUKE, LUO, AND KOLLM (AMBER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LD4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000102250. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 50 MM SODIUM PHOSPHATE REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5-1 MM [U-100% 15N] ANAMORSIN, REMARK 210 50 MM SODIUM PHOSPHATE, 2 MM DTT, REMARK 210 90% H2O/10% D2O; 0.5-1 MM [U- REMARK 210 100% 13C; U-100% 15N] ANAMORSIN, REMARK 210 50 MM SODIUM PHOSPHATE, 2 MM DTT, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H NOESY; 3D CBCA(CO)NH; REMARK 210 3D HNCO; 3D HNCA; 3D HNCACB; 3D REMARK 210 HBHA(CO)NH; 3D HN(CO)CA; 3D HCCH- REMARK 210 TOCSY; 3D 1H-15N NOESY; 3D 1H- REMARK 210 13C NOESY ALIPHATIC; 3D HN(CA)CO REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 900 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, CARA 2.0, CANDID, REMARK 210 TALOS, CYANA 1.3, PROCHECKNMR, REMARK 210 WHAT IF, PSVS REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-30 REMARK 465 RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 PHE A -1 REMARK 465 THR A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 55 -70.17 -64.46 REMARK 500 1 SER A 58 77.81 48.93 REMARK 500 1 SER A 59 -34.20 -130.12 REMARK 500 1 LEU A 67 56.80 -106.63 REMARK 500 1 ALA A 102 25.39 -150.63 REMARK 500 1 ASP A 104 -178.71 -56.66 REMARK 500 1 ASN A 106 -75.57 -60.00 REMARK 500 1 SER A 107 -167.45 52.81 REMARK 500 1 LEU A 147 -54.17 -127.19 REMARK 500 1 LEU A 155 130.24 -173.44 REMARK 500 1 GLU A 167 34.37 -179.26 REMARK 500 1 VAL A 168 -72.77 -149.92 REMARK 500 1 SER A 171 -74.68 -164.40 REMARK 500 2 SER A 58 83.63 51.79 REMARK 500 2 SER A 59 -39.10 -136.06 REMARK 500 2 LEU A 67 58.19 -107.45 REMARK 500 2 ALA A 102 40.73 -93.50 REMARK 500 2 ASP A 104 171.40 -52.86 REMARK 500 2 ASN A 106 -75.55 -70.66 REMARK 500 2 SER A 107 -169.15 52.31 REMARK 500 2 LEU A 147 -54.25 -127.98 REMARK 500 2 LEU A 155 130.06 -171.46 REMARK 500 2 PHE A 166 151.80 65.01 REMARK 500 2 SER A 171 -69.44 72.15 REMARK 500 3 SER A 58 73.50 48.25 REMARK 500 3 LEU A 67 59.60 -107.03 REMARK 500 3 ALA A 102 26.51 -153.29 REMARK 500 3 ASP A 104 -179.07 -57.24 REMARK 500 3 ASN A 106 -75.79 -60.99 REMARK 500 3 SER A 107 -166.78 54.63 REMARK 500 3 LEU A 147 -54.06 -127.18 REMARK 500 3 LEU A 155 130.39 -173.92 REMARK 500 3 PHE A 166 151.95 64.97 REMARK 500 3 VAL A 168 -41.55 -151.98 REMARK 500 3 SER A 170 -73.81 -152.15 REMARK 500 3 SER A 171 -176.09 56.54 REMARK 500 4 SER A 58 73.82 48.38 REMARK 500 4 LEU A 67 58.21 -108.35 REMARK 500 4 ALA A 102 39.94 -93.77 REMARK 500 4 ASP A 104 170.29 -52.94 REMARK 500 4 ASN A 106 -75.62 -68.99 REMARK 500 4 SER A 107 -168.02 52.38 REMARK 500 4 LEU A 147 -54.51 -128.31 REMARK 500 4 LEU A 155 130.36 -172.16 REMARK 500 4 PHE A 166 112.89 64.63 REMARK 500 4 GLU A 167 89.28 62.08 REMARK 500 5 HIS A 55 -71.76 -59.48 REMARK 500 5 SER A 58 84.41 60.16 REMARK 500 5 SER A 59 -37.24 -134.84 REMARK 500 5 LEU A 67 58.18 -105.29 REMARK 500 REMARK 500 THIS ENTRY HAS 361 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17646 RELATED DB: BMRB DBREF 2LD4 A 1 172 UNP Q6FI81 CPIN1_HUMAN 1 172 SEQADV 2LD4 GLY A -3 UNP Q6FI81 EXPRESSION TAG SEQADV 2LD4 SER A -2 UNP Q6FI81 EXPRESSION TAG SEQADV 2LD4 PHE A -1 UNP Q6FI81 EXPRESSION TAG SEQADV 2LD4 THR A 0 UNP Q6FI81 EXPRESSION TAG SEQRES 1 A 176 GLY SER PHE THR MET ALA ASP PHE GLY ILE SER ALA GLY SEQRES 2 A 176 GLN PHE VAL ALA VAL VAL TRP ASP LYS SER SER PRO VAL SEQRES 3 A 176 GLU ALA LEU LYS GLY LEU VAL ASP LYS LEU GLN ALA LEU SEQRES 4 A 176 THR GLY ASN GLU GLY ARG VAL SER VAL GLU ASN ILE LYS SEQRES 5 A 176 GLN LEU LEU GLN SER ALA HIS LYS GLU SER SER PHE ASP SEQRES 6 A 176 ILE ILE LEU SER GLY LEU VAL PRO GLY SER THR THR LEU SEQRES 7 A 176 HIS SER ALA GLU ILE LEU ALA GLU ILE ALA ARG ILE LEU SEQRES 8 A 176 ARG PRO GLY GLY CYS LEU PHE LEU LYS GLU PRO VAL GLU SEQRES 9 A 176 THR ALA VAL ASP ASN ASN SER LYS VAL LYS THR ALA SER SEQRES 10 A 176 LYS LEU CYS SER ALA LEU THR LEU SER GLY LEU VAL GLU SEQRES 11 A 176 VAL LYS GLU LEU GLN ARG GLU PRO LEU THR PRO GLU GLU SEQRES 12 A 176 VAL GLN SER VAL ARG GLU HIS LEU GLY HIS GLU SER ASP SEQRES 13 A 176 ASN LEU LEU PHE VAL GLN ILE THR GLY LYS LYS PRO ASN SEQRES 14 A 176 PHE GLU VAL GLY SER SER ARG HELIX 1 1 PRO A 21 THR A 36 1 16 HELIX 2 2 LYS A 48 ALA A 54 5 7 HELIX 3 3 SER A 76 ILE A 86 1 11 HELIX 4 4 THR A 111 SER A 122 1 12 HELIX 5 5 THR A 136 LEU A 147 1 12 SHEET 1 A 6 ARG A 41 ASN A 46 0 SHEET 2 A 6 PHE A 11 TRP A 16 1 N VAL A 14 O SER A 43 SHEET 3 A 6 PHE A 60 SER A 65 1 O LEU A 64 N VAL A 15 SHEET 4 A 6 LEU A 87 GLU A 100 1 O ARG A 88 N PHE A 60 SHEET 5 A 6 LEU A 154 LYS A 162 -1 O ILE A 159 N LEU A 95 SHEET 6 A 6 VAL A 125 GLU A 133 -1 N GLU A 133 O PHE A 156 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1